ImmuCell Corporation (NASDAQ:ICCC) Q1 2022 Earnings Conference Call May 13, 2022 9:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Michael Brigham - President and CEO Joseph Crabb - Former Chief Scientific Officer and VP Operator Good morning. This is Andrea from Chorus Call. I will be assisting with your conference call this morning. To get things started, let me ask Joe Diaz to open up the call. Joe Diaz Thank you, Andrea. Good morning, and welcome to everyone on the call this morning. My nam ...

ImmuCell Corp (NASDAQ:ICCC) Q4 2021 Earnings Conference Call February 23, 2022 9:00 AM ET Company Participants Michael Brigham – President, Chief Executive Officer Joe Diaz – Lytham Partner Betsy Williams – Vice President of Manufacturing Operations Bobbi Jo Brockmann – Vice President of Sales & Marketing Conference Call Participants George Melas – MKH Managements Tom Fox – Private Investor Operator Good morning and welcome to ImmuCell Corporation's fourth quarter fiscal year 2021 financial results. My name ...

ImmuCell Corp (NASDAQ:ICCC) Q3 2021 Earnings Conference Call November 16, 2021 9:00 AM ET Company Participants Joe Diaz - Lytham Partner Michael Brigham - President, CEO, Principal Financial Officer, Treasurer, Secretary & Director Conference Call Participants Scott Billeadeau - Walrus Partners Operator Good morning. This is Betsy from Chorus Call. I will be assisting with your conference call this morning. To get things started, let me ask Joe Diaz to open up the call. Joe Diaz Thank you, Betsy. Good morni ...

ImmuCell Corporation (NASDAQ:ICCC) Q2 2021 Earnings Conference Call August 13, 2021 9:00 AM ET Company Participants Joe Diaz - Managing Partner at Lytham Partners, LLC Michael Brigham - President and Chief Executive Officer Conference Call Participants Sam Rebotsky - SER Asset Management Operator Good day, and welcome to the ImmuCell Corporation reports Second Quarter 2021 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, t ...

| --- | --- | --- | --- | |----------------------------------------------------------|-------|-------|-------| | | | | | | ImmuCell Corporation Investor Presentation August 2021 | | | | | | | | | Forward-Looking Statements Cautionary Note Regarding Forward-Looking Statements (Safe Harbor Statement): This presentation contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are no ...

| --- | --- | --- | --- | |-------------------------------------------------------|-------|-------|-------| | | | | | | ImmuCell Corporation Investor Presentation May 2021 | | | | | | | | | Forward-Looking Statements Cautionary Note Regarding Forward-Looking Statements (Safe Harbor Statement): This presentation contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limi ...

ImmuCell Corporation (NASDAQ:ICCC) Q1 2021 Earnings Conference Call May 14, 2021 9:00 AM ET Company Participants Joe Diaz - Investor Relations Michael Brigham - President and Chief Executive Officer Conference Call Participants Sam Rebotsky - SER Asset Management Jenifer Taylor - MAC Funds Operator Good morning, everyone and welcome to the ImmuCell Corporation reports First Quarter of Fiscal Year 2021 Financial Results Conference Call. [Operator Instructions] Please also note today’s event is being recorded ...

ImmuCell Corporation (NASDAQ:ICCC) Q4 2020 Earnings Conference Call February 23, 2021 9:00 AM ET Company Participants Joe Diaz - Lytham Partners Michael F. Brigham - President and CEO Conference Call Participants Sam Rebotsky - SER Asset Management George Melas-Kyriazi - MKH Management Unidentified Analyst - Private Investor Louis Parks - Tyro Capital Management Operator Good morning and welcome to the ImmuCell Corporation reports Fourth Quarter Fiscal Year 2020 Financial Results Conference Call. All partic ...

| --- | --- | --- | --- | --- | |----------------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | ImmuCell Corporation Investor Presentation February 2021 | | | | | | | | | | | Forward-Looking Statements Cautionary Note Regarding Forward-Looking Statements (Safe Harbor Statement): Such statements include, but are not limited to, any statements relating to: our plans and strategies for our business; projections of future financial or operational performanc ...

ImmuCell Corporation (NASDAQ:ICCC) Q3 2020 Earnings Conference Call November 13, 2020 9:00 AM ET Company Participants Joe Diaz - Lytham Partners Michael Brigham - President and CEO Conference Call Participants Sam Rebotsky - SER Asset Management Operator Good morning and welcome to the ImmuCell Corporation reports Third Quarter Fiscal Year 2020 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity t ...